- Investigator
- Mark S Segal
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Cells, Cultured , 19 publications
- Biomarkers , 17 publications
- Kidney Failure, Chronic , 16 publications
- Hypertension , 16 publications
Research activity
Active clinical trials
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with鈥�
- Investigator
- Mark S Segal
- Status
- Accepting Candidates
- Ages
- 30 Years - 80 Years
- Sexes
- All
- Investigator
- Mark S Segal
- Status
- Accepting Candidates
My publications
Filter publications
161 publications
2024
Mobile Electrocardiograms in the Detection of Subclinical Atrial Fibrillation in High-Risk Outpatient Populations: Protocol for an Observational Study
JMIR Research Protocols
鈥�2024
Outcomes among Patients with End-Stage Kidney Disease and Chronic Limb-Threatening Ischemia: A Population-based Cohort Study.
Annals of surgery
鈥�2023
Initiative to improve the quality of patient care for chronic dialysis patients in the inpatient setting.
Hemodialysis international. International Symposium on Home Hemodialysis
鈥�2023
Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis.
Clinical immunology (Orlando, Fla.)
鈥�2023
National Treatment Patterns and Outcomes for Hospitalized Patients with Chronic Limb-Threatening Ischemia and End-Stage Kidney Disease.
Vascular and endovascular surgery
鈥�